(IN BRIEF) GSK and Shionogi have agreed with Pfizer to restructure ViiV Healthcare’s shareholder base, with Shionogi replacing Pfizer’s 11.7 percent economic interest and increasing its stake to 21.7 percent, while GSK maintains a 78.3 percent majority holding. The transaction, … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, Science, Technology, United Kingdom
Tagged biopharma partnership, cabotegravir, David Redfern, dolutegravir, GSK, HIV prevention, HIV treatment, integrase inhibitors, John Keller, long acting injectables, Pfizer, pharmaceutical industry, shareholder restructuring, Shionogi, strategic investment, ViiV Healthcare, ViiV Healthcare Ownership Streamlined with Expanded Shionogi Investment and GSK Majority
(IN BRIEF) At the XXIII FIGO World Congress of Gynecology and Obstetrics in Cape Town, six outstanding figures were honoured for their global impact on women’s health and rights. The FIGO Distinguished Merit Award was presented to Ethiopia’s Health Minister … Read the full press release
Posted in Awards, Healthcare, Management, News, Science, Society, United Kingdom
Tagged Afghanistan, Cape Town, Christine Solbach, ETHIOPIA, FIGO, FIGO World Congress in Cape Town Recognises Champions of Global Women’s Health and Empowerment, gender equality, Germany, global health, gynecology, health advocacy, HIV prevention, HPV vaccination, Japan, Jeannette Kagame, Linda-Gail Bekker, medical research, Mekdes Daba Feyssa, Obstetrics, reproductive health, Rwanda, Sima Samar, Six Global Leaders Honoured by FIGO for Outstanding Contributions to Women’s Health and Rights, South Africa, Tadashi Kimura, women's rights, Women’s Health, XXIII FIGO World Congress
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?